Does Medicaid Cover Weight Loss Shots in Virginia?

Yes, Virginia Medicaid does cover weight loss shots, including Wegovy, Saxenda, and Zepbound, but the program applies some of the country’s stricter clinical rules. You need a high BMI, documented failure of lifestyle changes and an older weight loss pill, and prior authorization from your prescriber before the pharmacy can fill it.¹

Who Qualifies for a GLP-1 Weight Loss Shot

The BMI bar for GLP-1 weight loss injections is high. Under the service authorization criteria effective June 1, 2026, you must have a BMI above 40, or a BMI above 37 with at least one qualifying condition: dyslipidemia, hypertension, or type 2 diabetes.² Those thresholds come from a 2024 state budget directive that tightened GLP-1 access beyond the earlier criteria.³

Your prescriber also has to certify that your obesity is “disabling and life threatening” and submit documentation from within the last 60 days showing your height, weight, medical status, and an individualized weight loss plan.²

Some members are excluded regardless of BMI. Pregnancy, lactation, a history of eating disorders, and a personal or family history of medullary thyroid cancer all disqualify you from GLP-1 coverage.²

What You Have to Try Before a Shot Is Approved

Virginia Medicaid does not approve weight loss injections as a first step. You have to show documented evidence that you tried and failed comprehensive lifestyle interventions, meaning nutritional counseling, a physical activity program, and behavioral modification.¹

Beyond lifestyle changes, GLP-1s carry a step-therapy rule: you must have tried and failed, or shown intolerance to, a non-GLP-1 weight loss medication first. Older oral drugs like phentermine, phendimetrazine, diethylpropion, benzphetamine, and orlistat sit at that lower step. You also have to have tried the specific product listed on Virginia’s Preferred Drug List.²

Which Injections Are Covered

Three GLP-1 weight loss injections are covered under Virginia Medicaid, each with its own age limits and rules:

Wegovy (semaglutide), for members aged 12 and older. Initial authorization runs six months, and renewal requires at least a 5% reduction in body weight.²
Saxenda (liraglutide), for members aged 12 and older. It is classified as a preferred GLP-1 weight loss drug on the state formulary.⁴
Zepbound (tirzepatide), for members aged 18 and older, under the same BMI and step-therapy rules as the others.²

Note what is not covered as a weight loss shot: Ozempic, Victoza, Mounjaro, Trulicity, and Rybelsus. DMAS classifies those as diabetic GLP-1 medications and does not authorize them for weight loss.⁴ You also cannot be taking a diabetes-indicated GLP-1 at the same time you receive authorization for a weight loss GLP-1.⁵

A separate injectable, Imcivree, is covered for a narrow group: members aged 2 and older with genetically confirmed obesity from BBS, POMC, PCSK1, or LEPR deficiency, prescribed by or in consultation with an endocrinologist or geneticist.²

How Long an Approval Lasts and What Renewal Takes

Initial authorization for a GLP-1 weight loss shot runs six months. To renew, you need to have lost at least 5% of your body weight since the most recent authorization.² The program does not list a maximum duration, so coverage can continue as long as you keep hitting the renewal benchmark.

There is a ceiling in the other direction. Once your BMI drops below 25, renewals are denied because the program treats that as a healthy weight. Imcivree runs on a different schedule: a four-month initial authorization, then one-year renewals that require at least a 5% reduction in body weight or baseline BMI.²

Managed Care Plans Can Set Different Rules

Most Virginia Medicaid members are enrolled in a managed care organization, not in fee-for-service. The rules above are the fee-for-service standards. DMAS has stated directly that managed care plans “may utilize different guidelines than those described for Medicaid fee-for-service individuals.”¹

The major MCOs in Virginia Medicaid are Aetna Better Health, Anthem HealthKeepers Plus, Humana Healthy Horizons, Sentara Community Plan, and United Healthcare Community Plan.⁶ For drugs on the state Preferred Drug List, MCOs must apply the same service authorization criteria as fee-for-service. For drugs not on the PDL, they can set their own.⁷ Aetna Better Health, for example, classifies Wegovy, Saxenda, and Zepbound as non-preferred weight management medications, so members typically have to try preferred options first.⁸

Check with your specific MCO before assuming the state criteria apply to you.

What to Do If You Are Denied

If your prior authorization is denied, your prescriber can request a peer-to-peer review with a physician at Prime Therapeutics, the pharmacy benefits administrator for fee-for-service. If the denial holds after that, the prescriber can escalate the appeal to DMAS for a final decision.⁹

You also have your own right to appeal. If you are in managed care, start with an internal appeal through your MCO. Anthem HealthKeepers Plus members, for instance, have 60 days from the denial date to appeal by phone, mail, fax, or member portal.¹⁰ After the MCO issues its final decision, you can request a review by the DMAS Appeals Division.¹¹

Fee-for-service members appeal directly to DMAS. The Appeals Division can be reached at 804-371-8488, by fax at 804-452-5454, or by email at appeals@dmas.virginia.gov. DMAS also operates an online portal called AIMS where you can submit documents and track your case.¹¹

Why the BMI Threshold Is So High Right Now

In 2024, Governor Glenn Youngkin’s administration raised the BMI threshold for GLP-1 weight loss drug coverage to above 40, or 37 with comorbidities, up from prior thresholds of 35 and above. In early 2026, the General Assembly adopted a budget amendment sponsored by Delegate Rodney Willett that would have lowered the threshold to a BMI of 35, or 30 with certain comorbidities.¹²

Governor Youngkin vetoed that provision on May 1, 2026, citing cost. His administration estimated the veto would save $7 million in state funds and nearly $40 million in federal funds.¹² The veto itself is contested. The House of Delegates Clerk rejected it as unconstitutional because the governor vetoed the coverage provision without also vetoing the associated appropriation, and Delegate Willett maintains the appropriation should be implemented. The governor’s office has said it will operate as if the veto stands, and the dispute may need a court to resolve.¹³ Until that is settled, the higher BMI threshold applies.

1
Virginia Department of Medical Assistance Services. Upcoming Changes to Service Authorization Criteria for Weight-Loss Drugs
2
Virginia Medicaid Pharmacy Services. Service Authorization Form: Weight-Loss Management
3
Virginia Legislative Information System. HB30, Item 288 #12c
4
Virginia Department of Medical Assistance Services. Report on Medicaid Expenditures for Diabetic and Weight Loss Drugs
5
Virginia Medicaid Pharmacy Services. Service Authorization Form: Anti-Obesity
6
Virginia Department of Medical Assistance Services. Preferred Drug List, Common Core Formulary, and Drug Utilization Review
7
Virginia Department of Medical Assistance Services. DMAS Pharmacy Manual, Chapter 4
8
Aetna Better Health of Virginia. Virginia FIDE Medicaid Formulary Updates
9
Virginia Medicaid Pharmacy Services. Frequently Asked Questions: General
10
Anthem. Complaints and Grievances
11
Virginia Department of Medical Assistance Services. Appeals
12
Richmond Times-Dispatch. Virginia Legislators Weigh Cost of Weight-Loss Drugs on Medicaid
13
Virginia Mercury. Virginia House Clerk Rejects Three of Gov. Glenn Youngkin’s Vetoes